Cancer BiologyJCO Precision OncologyPeer-reviewed
Organoids serve as viable in vitro model for functional precision medicine for mesonephric-like adenocarcinoma of the ovary
D Holthaus, Huy Duc Le, Laura Matzner…·Nina Hedemann
The paper demonstrates that ovarian cancer organoids derived from mesonephric-like adenocarcinoma can be used for functional precision medicine, showing sensitivity to binimetinib and resistance to standard chemotherapeutics.
DOI 10.1200/po-26-00661